Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

NCT01137695 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Pramlintide
DRUG: Pramlintide
DRUG: Pramlintide
DRUG: Pramlintide

Sponsor

Cheryl Rosenfeld, DO

Collaborators

[object Object]